Picture
 

Jessica Eye Failed UFC 166 Drug Test Due to Cannabinoids

Written by Tom Ngo
February 10th, 2014
Share on Facebook0Google+0Tweet about this on Twitter

UFC Jessica Eye

Oh, Jessica Eye (pictured). The cat’s out of the bag, so just admit it already. On Monday, the Texas Department of Licensing and Regulation confirmed the UFC bantamweight flunked her UFC 166 due to cannabinoids, a key component in marijuana.

BloodyElbow.com first reported the news, which was later confirmed by FoxSports.com.

Word broke earlier this month that Eye’s split decision victory over Sarah Kaufmann on October 19 was overturned to a no contest on January 22 because she had failed her drug screening. However, the prohibited substance found in Eye’s system remained under lock and key.

Red flags went up because Eye was merely issued a “probated suspension,” meaning she could keep her UFC 170 bout against Alexis Davis as long as she passes a pre-fight drug exam before the February 22 tango.

BleacherReport initially reported Eye tested positive for a blood-thinner that she’s been taking since she was hit by a drunk driver at the age of 16. However, Eye appeared as a guest on “The MMA Hour” today and refused to confirm why she failed the test – only admitting that “there were some mistakes that I made on my behalf that I didn’t give enough knowledge (to the commission) ahead of time.”

Host Ariel Helwani took to Twitter to address his disappointment after reading BloodyElbow’s report. “This [story] confirms JE didn’t tell the truth throughout our intv 2day.

“That’s disappointing. Reached out to her/her mgr to ask why. No response. Would also ask again: was this really worth all that fuss? But damn, from the timeline to the offense…that was just fantasyland. I was even wondering, why come on if you’re not gonna clear the air?”

As of now, Eye is still slated to meet Davis UFC 170. Needless to say, fight week will be very interesting because Eye has some ‘splainin’ to do.

Don’t forget to follow @5thRound on Twitter, Facebook and Google+!



COMMENTS